Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OSTEOTECH GRAFTON DRIVES REVENUE GROWTH IN 1997 WITH 74% U.S. SALES INCREASE; KENSEY NASH BREAKS EVEN ON ANGIO-SEAL ROYALTY STREAM IN SECOND QUARTER

This article was originally published in The Gray Sheet

Executive Summary

A 74% domestic sales increase for Osteotech's flagship Grafton demineralized bone matrix product in 1997 to $34.9 mil. led the company to a solid financial performance in the three and 12-month periods ended Dec. 31., as revenues increased 34% to $12.2 mil. and 28% to $36 mil. for the quarter and year, respectively.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT009521

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel